000 01353 a2200373 4500
005 20250511201149.0
264 0 _c19901114
008 199011s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19901001)66:7<1499::aid-cncr2820660711>3.0.co;2-g
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDunlap, N E
245 0 0 _aIn vitro natural killer and lymphokine-activated killer activity in patients with bronchogenic carcinoma.
_h[electronic resource]
260 _bCancer
_cOct 1990
300 _a1499-504 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aCarcinoma, Bronchogenic
_ximmunology
650 0 4 _aCells, Cultured
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferons
_xpharmacology
650 0 4 _aInterleukin-2
_xpharmacology
650 0 4 _aKiller Cells, Lymphokine-Activated
_xdrug effects
650 0 4 _aKiller Cells, Natural
_xdrug effects
650 0 4 _aLung Neoplasms
_ximmunology
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aLane, V G
700 1 _aCloud, G A
700 1 _aTilden, A B
773 0 _tCancer
_gvol. 66
_gno. 7
_gp. 1499-504
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19901001)66:7<1499::aid-cncr2820660711>3.0.co;2-g
_zAvailable from publisher's website
999 _c1704928
_d1704928